Surrozen, Inc. (SRZN)
NYSE · Common · CUSIP 86889P109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SRZN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
86889P109 (prev. G2445M129 )
Market Cap
Small Cap
IPO
11/19/2020
Previous Symbol
CHFW (changed 8/18/2021)
Previous Name
Consonance-HFW Acquisition Corp.
Business: Surrozen, Inc. is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Wnt signaling plays key roles in the control of development, homeostasis, and regeneration of many essential organs and tissues, and modulation of Wnt signaling has the potential for treatment of degenerative diseases and tissue injuries.

Company Contact

CEO
Craig Parker
CFO
Charles Williams
Headquarters
171 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080
Phone
650-489-9000
Investor Relations
investorinfo@surrozen.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
Find all related securities for SRZN »